Compounds, pharmaceutical compositions and methods for use...

Details Compounds, pharmaceutical compositions and methods for use... Compounds, pharmaceutical compositions and methods for use...

2005-02-24

2010-10-19

Davis, Zinna N (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S341000

Reexamination Certificate

active

07816367

ABSTRACT:
The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formulain-line-formulae description="In-line Formulae" end="lead"?Q-L1-P-L2-M-X-L3-Ain-line-formulae description="In-line Formulae" end="tail"?wherein the definitions of the variables Q, L1, P, L2, M, X, L3and A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.

REFERENCES:
patent: 3507881 (1970-04-01), Sandberg et al.
patent: 4760089 (1988-07-01), Chambers et al.
patent: 6037367 (2000-03-01), Christensen, IV et al.
patent: 6506757 (2003-01-01), Tajima et al.
patent: 6645939 (2003-11-01), Durette et al.
patent: 6710063 (2004-03-01), Chao et al.
patent: 6723740 (2004-04-01), Chao et al.
patent: 6875780 (2005-04-01), Auerbach et al.
patent: 6939875 (2005-09-01), Auerbach et al.
patent: 6964983 (2005-11-01), Auerbach et al.
patent: 7338960 (2008-03-01), Bell et al.
patent: 7345068 (2008-03-01), Endou et al.
patent: 2004/0058965 (2004-03-01), Momose et al.
patent: 2005/0089866 (2005-04-01), Hinuma et al.
patent: 2005/0119256 (2005-06-01), Endo et al.
patent: 2006/0003344 (2006-01-01), Houseknecht et al.
patent: 2006/0004012 (2006-01-01), Akerman et al.
patent: 2006/0270724 (2006-11-01), Houze et al.
patent: 27141/77 (1979-01-01), None
patent: 52306/93 (1994-06-01), None
patent: 2111035 (1994-06-01), None
patent: 27 33 305 (1977-07-01), None
patent: 42 41 632 (1994-06-01), None
patent: 199 41 567 (2000-04-01), None
patent: 0 250 264 (1987-12-01), None
patent: 0 414 289 (1991-02-01), None
patent: 1 357 115 (2003-10-01), None
patent: 1 380 562 (2004-01-01), None
patent: 1 535 915 (2005-06-01), None
patent: 1 559 422 (2005-08-01), None
patent: 1 630 152 (2006-03-01), None
patent: 10-316641 (1998-12-01), None
patent: 2001 242165 (2001-09-01), None
patent: 2002 003368 (2002-01-01), None
patent: WO 93/23040 (1993-11-01), None
patent: WO 93/23041 (1993-11-01), None
patent: WO 95/01326 (1995-01-01), None
patent: WO 95/01348 (1995-01-01), None
patent: WO 96/40097 (1996-12-01), None
patent: WO 97/10819 (1997-03-01), None
patent: WO 97/12853 (1997-04-01), None
patent: WO 97/12867 (1997-04-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 99/30709 (1999-06-01), None
patent: WO 99/62871 (1999-12-01), None
patent: WO 00/63196 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/68223 (2000-11-01), None
patent: WO 00/74666 (2000-12-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO 01/36351 (2001-05-01), None
patent: WO 01/36365 (2001-05-01), None
patent: WO 02/053547 (2002-07-01), None
patent: WO 02/057783 (2002-07-01), None
patent: WO 02/062774 (2002-08-01), None
patent: WO 02/100403 (2002-12-01), None
patent: WO 02/100812 (2002-12-01), None
patent: WO 03/068959 (2003-08-01), None
patent: WO 03/074050 (2003-09-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 2004/000315 (2003-12-01), None
patent: WO 2004/000915 (2003-12-01), None
patent: WO 2004/022551 (2004-03-01), None
patent: WO 2004/041266 (2004-05-01), None
patent: WO 2004/092117 (2004-10-01), None
patent: WO 2004/106276 (2004-12-01), None
patent: WO 2005/051890 (2005-06-01), None
patent: WO 2005/058848 (2005-06-01), None
patent: WO 2005/063725 (2005-06-01), None
patent: WO 2005/063729 (2005-07-01), None
patent: WO 2005/087710 (2005-09-01), None
patent: WO 2006/001092 (2006-01-01), None
patent: WO 2006/011615 (2006-02-01), None
patent: WO 2006/083612 (2006-08-01), None
patent: WO 2006/083781 (2006-08-01), None
Vincent et al, Analytical Chemistry (1997), 69(21), 4419-4428.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Booth, C. J. et al., “The Synthesis and Transition Temperatures of Novel Low Molar Mass Chosesteric materials Derives from (R)-2-(4-Hydroxyphenoxy)propanoic Acid,” Mol. Cryst. Liq. Cryst., vol. 210, pp. 31-57 (1992).
Booth, C. J. et al., “The Influence of the Liquid Crystalline Core Geometry on the Mesogenicity of Novel Chiral 2-(4-Substituted-phenoxy)propanonitriles,” Liquid Crystals, vol. 16(6), pp. 925-940, (1994).
Bachmann, et al., “The Synthesis of an Analog of the Sex Hormones”,Jnl. Amer. Chem. Soc., 64: 94-97 (1942).
Berthelot, et al., “Synthesis and Pharmacological Evaluation of γ-Aminobutyric Acid Analogues. New Ligand for GABABSites”,Jnl. Med. Chem., 30: 743-746 (1987).
Boyle, et al., “Applications of the spiroannulation of tetralins with alkynes; towards new anti-estrogenic compounds”,Jnl. Chem. Soc., Perkin Trans. Org. and Bioorg. Chem., 18: 2707-2711 (1997).
Briscoe, et al., “The Orphan G Protein-Coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids”,Jnl. of Biol. Chem., 278: 11303-11311 (2003).
Briscoe, et al., “Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules”,Brit. Jnl. of Pharm., 148: 619-628 (2006).
Burnop, et al., “Fused Carbon Rings. Part XIX. Experiments on the Synthesis of Tetracyclic Compounds of the Sexual Hormonal Type”,Jnl. Chem. Soc., 727-735 (1940).
Chatterjee, et al., “Studies on Nucleophilic Ring Opening of Some Epoxides in Polar Protic Solvents”,Tetr., 33: 85-94 (1977).
Collins, et al., “The Structure and Function of Oestrogens. IX. Synthesis of thetransIsomer of 5,5,10b-Trimethy1-4b,5,6,10b,11,12-hexahydrochrysene-2,8-diol”,Aust. Jnl. Chem., 41: 735-744 (1988).
Deb, et al., “A Stereocontrolled Synthesis of (1′RS,2′SR)-3-Oxo-3',4'-dihydrospiro[cyclopentane-1,1′(2′H)-naphthalen]-2-ylacetic Acid and its Methoxy Analogues”,Jnl. Chem. Res. S., 12: 406 (1985).
DeWolf, et al., “Inactivation of Dopamine β-Hydroxylase by β-Ethynyltyramine: Kinetic Characterization and Covalent Modification of an Active Site Peptide”,Biochem., 28: 3833-3842 (1989).
Egan, et al., “Naphthalenes as inhibitors of myeloperoxidase: Direct and indirect mechanisms of inhibition”,Agents and Actions, 29¾, 266-276 (1990).
Frey, et al., “Total Synthesis of Pentacyclic Diterpenoid Tropone Hainanolidol,”Aust. Jnl. Chem., 53: 819-830 (2000).
Galemmo, et al., “The Development of a Novel Series of (Quinolin-2-ylmethoxy) phenyl-Containing Compounds as High-Affinity Leukotriene Receptor Antagonists. 3. Structural Variation of the Acidic Side Chain To Give Antagonists of Enhanced Potency”,Jnl. Med. Chem., 33: 2828-2841 (1990).
Garrido, et al., “Synthesis and activity of small molecule GPR40 agonists,”Bioorg. and Med. Chem. Lett., 16: 1840-1845 (2006).
Ghosal, et al., “Stereospecific Synthesis of 9bβ-Carbomethoxy-7-Methoxy-2,3,3aα,4,5,9bβHexahydro-1H-Benz[e]Inden-2-one; An Intermediate Towards Physiologically Active Compounds,”Tet. Lett., 17: 1463-1464 (1977).
Guthrie, et al., “Synthesis in the Series of Diterpene Alkaloids VI. A Simple Synthesis of Atisine,”Tet. Lett., 38: 4645-4654 1966.
Haigh, et al., “Non-thiazolidinedione Antihyperglycaemic Agents. Part 3: The Effects of Stereochemistry on the Potency of α-Methoxy-β-phenylpropanoic Acids,”Bioorg.&Med. Chem.,7: 821-830 (1999).
Hares, et al., “Synthetic Studies of Tricyclospirodienones; Model Chemistry for Novel Mimics of Steroid Substrates”,Jnl. Chem. Soc. Perkin Trans. I: Org. and Bioorg. Chem., 13 1481-1492 (1993).
Iizuka, et al., “β-Substituted Phenethylamines as High Affinity Mechanism-Based Inhibitors of Dopamine β-Hydroxylase”,Jnl. Med. Chem., 31: 704-706 (1988).
Ishikawa, et al., “Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin—dependent diabetes mellitus model animals”,Diabetes Rsh. and Clin. Pract., 41: 101-111 (1998).
Ishikawa, et al., “Effects of the novel oral a

Affiliated with

Also associated with

Rating

Compounds, pharmaceutical compositions and methods for use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, pharmaceutical compositions and methods for use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, pharmaceutical compositions and methods for use... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4200501